Exhibit 99.1

Press Release

For Further Information Contact:

INVESTORS:	MEDIA:
investor@riteaid.com	Karen Rugen
	(717) 730-7766

Rite Aid Reports Fiscal Year 2009 Second Quarter Net Loss Per Diluted Share of $0.27 and Adjusted EBITDA of $215.3 Million

Core Rite Aid Same Store Sales Increased 3.1 Percent from Prior Year, While Sales in Acquired Stores Continued To Improve

Brooks Eckerd Integration on Schedule for Completion by September 30

Management Takes Further Actions to Reduce Costs, Improve Cash Flows

Company Revises Outlook for Fiscal Year 2009

CAMP HILL, PA – September 25, 2008 – Rite Aid Corporation (NYSE: RAD) today reported revenues of $6.50 billion and a net loss of $222.0 million or $0.27 per diluted share for its fiscal second quarter ended August 30, 2008.  Solid front-end and pharmacy sales in core Rite Aid stores were offset by the expected decrease in sales at acquired stores.  All results and comparisons include the Brooks Eckerd stores and distribution centers, which the company acquired on June 4, 2007.

Second Quarter Highlights

· Overall same store sales increased 0.6 percent year-over-year due to solid performance in core stores.

· Same store sales in Brooks Eckerd stores continued to show progress, narrowing to a decline of 4.1 percent from the year-ago period versus 6.7 percent in the first quarter.

· Front end same store sales in the acquired stores turned positive for the month of August.

· Company generated positive cash flow of $96.1 million from operations.

· Liquidity strengthened by $700 million refinancing and increased sale and leaseback transactions.

- MORE -

Rite Aid Press Release – page 2

“In this tough retail environment, our core stores delivered solid performance, we made significant progress building our acquired stores’ front-end sales, we took steps to increase our financial flexibility and we largely completed the integration of Brooks Eckerd.  We also improved our gross profit rate in spite of what has turned out to be a heavily promotional environment in pharmacy as well as front end,” said Mary Sammons, Rite Aid chairman, president and CEO.

“While improving the acquired stores’ pharmacy business will take longer than originally expected,  we are encouraged by the trends we’re seeing in these stores and the initiatives we have in place to grow prescriptions, even in today’s low growth environment.  The stores look great, our associates are upbeat and customers we lost during the disruption of the integration are starting to return.  With the Brooks Eckerd integration completed in just a few days, we will be in a better position to more fully realize the strategic benefits of the acquisition,” Sammons said.

Actions to Further Reduce Costs and Improve Cash Flows

The company also announced a series of actions to further reduce costs and improve cash flows in the second half of its fiscal year. These actions include:

· Reducing operating expenses through improved efficiency

· Cutting capital expenditures by approximately $50 million and

· Pursuing additional sale and leaseback transactions.

“The increasingly challenging economic environment underscores the importance of managing our business prudently, while maintaining our commitment to delivering the high level of service our customers expect.  Moving forward, we are taking additional steps to reduce costs to further strengthen our financial position and build on the steps we have taken to improve working capital, which is already delivering results,” Sammons said.

The company said it expects to use free cash flow to reduce the outstanding balance on its revolving credit facility at the end of fiscal 2009.

Second Quarter Summary

Revenues for the 13-week second quarter were $6.50 billion versus revenues of $6.57 billion in the prior year second quarter.  Revenues decreased 1.1 percent, primarily as a result of the decline in sales at the Brooks Eckerd stores and the impact from closing underperforming stores and combining stores in close proximity.

Same store sales for the quarter increased 0.6 percent over the prior year 13-week period, consisting of a 1.9 percent increase in the front end and flat same store sales in the pharmacy.  Pharmacy sales included an approximate 264 basis point negative impact from new generic introductions.  The number of prescriptions filled decreased 1.7 percent, negatively impacted by the acquired stores.  The number of prescriptions filled increased in core Rite Aid stores.  Prescription sales accounted for 66.9 percent of total sales, and third party prescription sales represented 96.4 percent of pharmacy sales.

Excluding the acquired Brooks Eckerd stores, same stores sales for the 13-week second quarter increased 3.1 percent over the prior-year period with front end increasing 3.6 percent and pharmacy growing 2.8 percent.

- MORE -

Rite Aid Press Release – page 3

At the Brooks Eckerd stores, same store sales for the 13-week second quarter decreased 4.1 percent over the prior-year period, an improvement over the first quarter’s decrease of 7.2 percent.  Front end decreased 2.7 percent in the second quarter but turned positive for the month of August.  Pharmacy decreased 4.6 percent in the second quarter.

Net loss for the second quarter was $222.0 million or $.27 per diluted share compared to last year’s second quarter net loss of $69.6 million or $.10 per diluted share.  The net loss included the expected expense of $36.2 million from the refinancing in the second quarter and expected income tax expense of $5.3 million compared to an income tax benefit in the prior year’s second quarter.  Also contributing to the net loss was a decrease in adjusted EBITDA of $46.2 million, an increase in store closing and impairment charges of $35.2 million and an increase in depreciation and amortization expense of $18.4 million.

Adjusted EBITDA was $215.3 million or 3.3 percent of revenues for the second quarter compared to

$261.5 million or 4.0 percent of revenues for the like period last year.  An increase in gross profit rate was not enough to offset the sales decline and related lost gross profit in the Brooks Eckerd stores, and an increase in expenses.  Expenses as a percent of revenues were higher, primarily due to expected occupancy expenses related to both the company’s new and relocated store program and sale and leaseback transactions, and an increase in wage and benefits expense.

In the second quarter, the company opened 8 stores, relocated 17 stores, acquired 1 store, remodeled 22 stores and closed 83 stores.  Most of the stores that were closed were the result of the stores’ performance.  Combining acquired stores in close proximity to existing stores accounted for 26 of the closed stores.  Stores in operation at the end of the second quarter totaled 4,930.

During the quarter, the company also completed an approximately $700 million refinancing to fund the retirement of  several notes that had restricted the company’s ability to borrow the full availability of its $1.75 billion revolving credit facility.

Company Revises Fiscal 2009 Guidance

Based on current sales trends, a longer-than-expected turnaround of Brooks Eckerd pharmacy sales,   economists’ forecasts for continued weakness in the economy, the closing of underperforming stores and the company’s planned cost reductions for the remainder of its fiscal year, Rite Aid has revised its fiscal 2009 guidance.

Sales are expected to be between $26.0 billion and $26.5 billion in fiscal 2009 with same store sales expected to improve 1.5 percent to 3.0 percent over fiscal 2008.  Adjusted EBITDA is expected to be between $950 million and $1.025 billion.  Net loss for fiscal 2009 is expected to be between $445 million and $535 million or a loss per diluted share of $.56 to $.67.  Capital expenditures, excluding proceeds from sale and leaseback transactions, are expected to be approximately $550 million.  Proceeds from sale and leaseback transaction are expected to be approximately $200 million.  (See attached chart for previous guidance).

- MORE -

Rite Aid Press Release – page 4

Conference Call Broadcast

Rite Aid will hold an analyst call at 8:30 a.m. Eastern Time today with remarks by Rite Aid's management team. The call will be simulcast via the internet and can be accessed through the websites www.riteaid.com in the conference call section of investor information and www.StreetEvents.com.  A playback of the call will be available on both sites starting at 2 p.m. Eastern Time today.  A playback of the call will also be available by telephone for 48 hours beginning at 12 p.m. Eastern Time today until 12 p.m. Eastern Time on September 27.  The playback number is 1-800-642-1687 from within the U.S. and Canada or 1-706-645-9291 from outside the U.S. and Canada with the eight-digit reservation number 63877888.

Rite Aid Corporation is one of the nation’s leading drugstore chains with more than 4,900 stores in 31 states and the District of Columbia.  Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com.

This press release contains forward-looking statements, including guidance, which are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include our high level of indebtedness; our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements; our ability to improve the operating performance of our stores in accordance with our long term strategy, our ability to realize the benefits of the Brooks Eckerd acquisition, including positive same store sales growth for Brooks Eckerd and cost savings; our ability to hire and retain pharmacists and other store personnel; the efforts of private and public third-party payors to reduce prescription drug reimbursements and encourage mail order; competitive pricing pressures, including aggressive promotional activity from our competitors; our ability to manage expenses, including integration expenses; our ability to realize the benefits from actions to further reduce costs and investment in working capital; continued consolidation of the drugstore industry; changes in state or federal legislation or regulations; the outcome of lawsuits and governmental investigations; general economic conditions and inflation and  interest rate movements and  access to capital, including our continuing ability to complete sale and leaseback transactions.  Consequently, all of the forward-looking statements made in this press release, including our guidance, are qualified by these and other factors, risks and uncertainties.  Readers are also directed to consider other risks and uncertainties discussed in documents filed by the Company with the Securities and Exchange Commission. Forward-looking statements can be identified through the use of words such as "may", "will", "intend", "plan", "project", "expect", "anticipate", "could", "should", "would", "believe", "estimate", "contemplate", and "possible".

See the attached table for a reconciliation of a non-GAAP financial measure, Adjusted EBITDA to net income (loss), the most comparable GAAP financial measure. We define Adjusted EBITDA as net income (loss) from operations excluding the impact of income taxes, interest expense, depreciation and amortization, LIFO adjustments, charges or credits for store closing and impairment, inventory write-downs related to closed stores, stock-based compensation expense, debt modifications and retirements, sale of assets and investments and other non-recurring items. We reference this non-GAAP financial measure frequently in our decision-making because it provides supplemental information that facilitates internal comparisons to the historical operating performance of prior periods and external comparisons to competitors’ historical operating performance. In addition, incentive compensation is based on Adjusted EBITDA and we base our forward-looking estimates on Adjusted EBITDA to facilitate quantification of planned business activities and enhance subsequent follow-up with comparisons of actual to planned Adjusted EBITDA. We include this non-GAAP financial measure in our earnings announcement in order to provide transparency to our investors and enable investors to better compare our operating performance with the operating performance of our competitors.

###

RITE AID CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
(unaudited)
	August 30,			March 1,
	2008			2008
ASSETS
Current assets:
Cash and cash equivalents	$	170,260		$	155,762
Accounts receivable, net		592,662			665,971
Inventories, net of LIFO reserve of $592,917 and $562,729		3,958,193			3,936,827
Prepaid expenses and other current assets		179,494			163,334
Total current assets		4,900,609			4,921,894
Property, plant and equipment, net		2,785,671			2,873,009
Goodwill		1,810,223			1,783,372
Other intangibles, net		1,137,630			1,187,327
Deferred tax assets		355,533			384,163
Other assets		363,994			338,258
Total assets	$	11,353,660		$	11,488,023
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current maturities of long-term debt and lease financing obligations	$	39,822		$	185,609
Accounts payable		1,467,059			1,425,768
Accrued salaries, wages and other current liabilities		1,029,150			1,110,288
Deferred tax liabilities		47,744			76,374
Total current liabilities		2,583,775			2,798,039
Long-term debt, less current maturities		5,976,875			5,610,489
Lease financing obligations, less current maturities		199,940			189,426
Other noncurrent liabilities		1,247,658			1,178,884
Total liabilities		10,008,248			9,776,838
Commitments and contingencies		-			-
Stockholders' equity:
Preferred stock - Series G		144,169			139,253
Preferred stock - Series H		139,288			135,202
Preferred stock - Series I		58,358			116,415
Common stock		843,472			830,209
Additional paid-in capital		4,095,446			4,047,499
Accumulated deficit		(3,915,926	)		(3,537,276	)
Accumulated other comprehensive loss		(19,395	)		(20,117	)
Total stockholders' equity		1,345,412			1,711,185
Total liabilities and stockholders' equity	$	11,353,660		$	11,488,023

RITE AID CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share amounts)
(unaudited)
	Thirteen Weeks ended  August 30, 2008			Thirteen Weeks ended  September 1, 2007
Revenues	$	6,500,244		$	6,573,699
Costs and expenses:
Cost of goods sold		4,722,070			4,783,888
Selling, general and administrative expenses		1,780,631			1,742,148
Store closing and impairment charges		51,825			16,587
Interest expense		118,565			123,250
Loss on debt modifications and retirements, net		36,197			-
Acquisition related financing commitment charge		-			12,900
Loss on sale of assets, net		7,607			1,651
		6,716,895			6,680,424
Loss from continuing operations before income taxes		(216,651	)		(106,725	)
Income tax expense (benefit)		5,346			(38,570	)
Net loss from continuing operations		(221,997	)		(68,155	)
Loss from discontinued operations		-			(1,443	)
Net loss	$	(221,997	)	$	(69,598	)
Basic and diluted loss per share:
Numerator for loss per share:
Net loss	$	(221,997	)	$	(69,598	)
Accretion of redeemable preferred stock		(26	)		(26	)
Cumulative preferred stock dividends		(5,368	)		(8,097	)
Preferred stock beneficial conversion		-			(480	)
Loss attributable to common stockholders - basic and diluted	$	(227,391	)	$	(78,201	)
Denominator:
Basic and diluted weighted average shares		837,913			781,805
Basic and diluted loss per share	$	(0.27	)	$	(0.10	)

RITE AID CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in thousands, except per share amounts)
(unaudited)
	Twenty-six Weeks ended August 30, 2008			Twenty-six Weeks ended September 1, 2007
Revenues	$	13,113,100		$	11,004,112
Costs and expenses:
Cost of goods sold		9,526,680			7,998,722
Selling, general and administrative expenses		3,573,605			2,861,790
Store closing and impairment charges		88,087			20,617
Interest expense		236,805			191,975
Loss on debt modifications and retirements, net		39,905			-
Acquisition related financing commitment charge		-			12,900
Loss (gain) on sale of assets, net		12,947			(2,579	)
		13,478,029			11,083,425
Loss from continuing operations before income taxes		(364,929	)		(79,313	)
Income tax expense (benefit)		10,339			(39,470	)
Net loss from continuing operations		(375,268	)		(39,843	)
Loss from discontinued operations		(3,369	)		(2,121	)
Net loss	$	(378,637	)	$	(41,964	)
Basic and diluted loss per share:
Numerator for loss per share:
Net loss	$	(378,637	)	$	(41,964	)
Accretion of redeemable preferred stock		(51	)		(51	)
Cumulative preferred stock dividends		(11,490	)		(16,127	)
Preferred stock beneficial conversion		-			(556	)
Loss attributable to common stockholders - basic and diluted	$	(390,178	)	$	(58,698	)
Denominator:
Basic and diluted weighted average shares		830,499			656,422
Basic and diluted loss per share	$	(0.47	)	$	(0.09	)

RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(In thousands)
	Thirteen Weeks ended August 30, 2008			Thirteen Weeks ended September 1, 2007
Reconciliation of net loss to adjusted EBITDA:
Net loss	$	(221,997	)	$	(69,598	)
Adjustments:
Interest expense		118,565			123,250
Income tax expense (benefit)		5,346			(39,347	)
Depreciation and amortization		150,901			132,492
LIFO charges (a)		15,094			16,041
Store closing and impairment charges		51,825			16,587
Stock-based compensation expense		7,524			11,960
Loss on sale of assets, net		7,607			1,651
Loss on debt modifications and retirements, net (b)		36,197			-
Acquisition related financing commitment charge (c)		-			12,900
Incremental acquisition costs (d)		32,385			52,101
Closed store liquidation expense (e)		5,675			2,300
Other		6,129			1,137
Adjusted EBITDA	$	215,251		$	261,474
Percent of revenues		3.31	%		3.96	%
Results of discontinued operations (f)		-			1,955
Adjusted EBITDA from continuing operations	$	215,251		$	263,429

Notes:
	(a)	Represents non-cash charges to value our inventories under the last-in first-out ("LIFO") method.
	(b)	Represents loss related to debt modifications and retirements, net
	(c)	Represents a charge for financing commitments related to the acquisition of Jean Coutu, USA.
	(d)	Represents incremental costs related to the acquisition of Jean Coutu, USA.
	(e)	Represents costs to liquidate inventory at stores that are in the process of closing.
	(f)	Represents losses from our recently disposed Las Vegas market that are included in Adjusted EBITDA.

RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(In thousands)
	Twenty-six Weeks ended August 30, 2008			Twenty-six Weeks ended September 1, 2007
Reconciliation of net loss to adjusted EBITDA:
Net loss	$	(378,637	)	$	(41,964	)
Adjustments:
Interest expense		236,805			191,975
Income tax expense (benefit)		10,339			(40,612	)
Depreciation and amortization		295,942			200,411
LIFO charges (a)		30,188			25,332
Store closing and impairment charges		88,087			20,617
Stock-based compensation expense		16,203			18,574
Loss (gain) on sale of assets, net		12,995			(2,579	)
Loss on debt modifications and retirements, net (b)		39,905			-
Acquisition related financing commitment charge (c)		-			12,900
Incremental acquisition costs (d)		76,876			63,266
Closed store liquidation expense (e)		10,535			4,399
Other		12,442			1,971
Adjusted EBITDA	$	451,680		$	454,290
Percent of revenues		3.44	%		4.11	%
Results of discontinued operations (f)		1,882			2,737
Adjusted EBITDA from continuing operations	$	453,562		$	457,027

Notes:
	(a)	Represents non-cash charges to value our inventories under the last-in first-out ("LIFO") method.
	(b)	Represents loss related to debt modifications and retirements, net
	(c)	Represents a charge for financing commitments related to the acquisition of Jean Coutu, USA.
	(d)	Represents incremental costs related to the acquisition of Jean Coutu, USA.
	(e)	Represents costs to liquidate inventory at stores that are in the process of closing.
	(f)	Represents losses from our recently disposed Las Vegas market that are included in Adjusted EBITDA.

RITE AID CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands) (unaudited)
	Thirteen Weeks ended August 30, 2008			Thirteen Weeks ended September 1,  2007
OPERATING ACTIVITIES:
Net loss	$	(221,997	)	$	(69,598	)
Adjustments to reconcile to net cash provided by (used in) operating activities:
Depreciation and amortization		150,901			132,492
Store closing and impairment charges		51,825			16,587
LIFO charges		15,094			16,041
Loss on sale of assets, net		7,607			1,651
Stock-based compensation expense		7,524			11,960
Loss on debt modifications and retirements, net		36,197			-
Acquisition related financing commitment charge		-			12,900
Changes in deferred taxes		-			(40,163	)
Proceeds from sale of inventory		-			8,156
Proceeds from insured loss		-			1,292
Changes in operating assets and liabilities:
Net repayments to accounts receivable securitization		(5,000	)		(90,000	)
Accounts receivable		56,587			99,600
Inventories		(44,091	)		(265,144	)
Accounts payable		133,900			24,144
Other assets and liabilities, net		(92,428	)		450
Net cash provided by (used in) operating activities		96,119			(139,632	)
INVESTING ACTIVITIES:
Payments for property, plant and equipment		(153,079	)		(162,186	)
Intangible assets acquired		(25,342	)		(15,909	)
Expenditures for business acquisition		-			(1,119,066	)
Proceeds from sale-leaseback transactions		73,933			10,550
Proceeds from dispositions of assets and investments		13,953			8,397
Proceeds from insured loss		-			408
Net cash used in investing activities		(90,535	)		(1,277,806	)
FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt		740,764			1,105,000
Net (payments to) proceeds from revolver		(22,000	)		342,000
Proceeds from financing secured by owned property		20,134			-
Principal payments on long-term debt		(700,225	)		(4,018	)
Change in zero balance cash accounts		14,518			87,671
Net proceeds from the issuance of common stock		-			2,753
Payments for preferred stock dividends		(831	)		(3,845	)
Excess tax deduction on stock options		-			2,651
Financing costs paid		(39,873	)		(56,132	)
Net cash provided by financing activities		12,487			1,476,080
Increase in cash and cash equivalents		18,071			58,642
Cash and cash equivalents, beginning of period		152,189			111,690
Cash and cash equivalents, end of period	$	170,260		$	170,332

RITE AID CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) (unaudited)
	Twenty-six Weeks ended August 30,  2008			Twenty-six Weeks ended September 1,  2007
OPERATING ACTIVITIES:
Net loss	$	(378,637	)	$	(41,964	)
Adjustments to reconcile to net cash (used in) provided by operating activities:
Depreciation and amortization		295,942			200,411
Store closing and impairment charges		88,087			20,617
LIFO charges		30,188			25,332
Loss (gain) on sale of assets, net		12,995			(2,579	)
Stock-based compensation expense		16,203			18,574
Loss on debt modifications and retirements, net		39,905			-
Acquisition related financing commitment charge		-			12,900
Changes in deferred taxes		-			(39,002	)
Proceeds from sale of inventory		-			8,156
Proceeds from insured loss		-			8,550
Changes in operating assets and liabilities:
Net proceeds from (repayments to) accounts receivable securitization		65,000			(60,000	)
Accounts receivable		7,745			56,590
Inventories		(95,194	)		(256,035	)
Accounts payable		16,971			75,324
Other assets and liabilities, net		(108,414	)		19,778
Net cash (used in) provided by operating activities		(9,209	)		46,652
INVESTING ACTIVITIES:
Payments for property, plant and equipment		(302,955	)		(279,686	)
Intangible assets acquired		(61,464	)		(29,710	)
Expenditures for business acquisition		(112	)		(2,356,578	)
Proceeds from sale-leaseback transactions		161,553			10,550
Proceeds from dispositions of assets and investments		18,629			13,108
Proceeds from insured loss		-			5,950
Net cash used in investing activities		(184,349	)		(2,636,366	)
FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt		898,764			2,306,005
Net proceeds from revolver		164,000			303,000
Proceeds from financing secured by owned property		31,266			-
Principal payments on long-term debt		(855,190	)		(7,209	)
Change in zero balance cash accounts		20,060			100,617
Net proceeds from the issuance of common stock		1,117			11,848
Payments for preferred stock dividends		(2,488	)		(7,690	)
Excess tax deduction on stock options		-			5,522
Financing costs paid		(49,473	)		(58,195	)
Net cash provided by financing activities		208,056			2,653,898
Increase in cash and cash equivalents		14,498			64,184
Cash and cash equivalents, beginning of period		155,762			106,148
Cash and cash equivalents, end of period	$	170,260		$	170,332

RITE AID CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION
RECONCILIATION OF NET LOSS GUIDANCE TO ADJUSTED EBITDA GUIDANCE
YEAR ENDING FEBRUARY 28, 2009
(In thousands, except per share amounts)
	Guidance Range						Previous Guidance Range
	Low			High			Low			High
Sales	$	26,000,000		$	26,500,000		$	26,700,000		$	27,200,000
Same store sales		1.50	%		3.00	%		2.00	%		4.00	%
Gross capital expenditures	$	550,000		$	550,000		$	600,000		$	600,000
Sale and leaseback proceeds	$	200,000		$	200,000		$	150,000		$	150,000
Reconciliation of net loss to adjusted EBITDA:
Net loss	$	(535,000	)	$	(445,000	)	$	(415,000	)	$	(300,000	)
Adjustments:
Interest expense		495,000			490,000			495,000			490,000
Income tax expense		12,000			7,000			12,000			7,000
Depreciation and amortization		565,000			565,000			545,000			545,000
LIFO charge		60,000			55,000			60,000			55,000
Store closing, liquidation, and impairment charges		140,000			140,000			110,000			110,000
Non recurring Brooks-Eckerd integration expenses		100,000			100,000			110,000			110,000
Stock-based compensation expense		38,000			38,000			38,000			38,000
Loss on debt modification		40,000			40,000			40,000			40,000
Other		35,000			35,000			5,000			5,000
Adjusted EBITDA	$	950,000		$	1,025,000		$	1,000,000		$	1,100,000
Diluted loss per share	$	(0.67	)	$	(0.56	)	$	(0.52	)	$	(0.39	)